reports
Moody's affirms AstraZeneca's A3 ratings; changes outlook to negative ...
Rating Action: Moody's affirms AstraZeneca's A3 ratings; changes outlook to negative from stable. Global Credit Research- 15 Dec 2020. London, 15 December 2020-- Moody's Investors Service has today affirmed AstraZeneca PLC's A3 senior unsecured ratings and P-2 short-term commercial paper rating.
Moody's announces completion of a periodic review of ratings of AstraZ...
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of AstraZeneca PLC. Global Credit Research- 07 Aug 2020. London, 07 August 2020-- Moody's Investors Service has completed a periodic review of the ratings of AstraZeneca PLC and other ratings that are associated with the same analytical unit.
Moody's announces completion of a periodic review of ratings of AstraZ...
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of AstraZeneca PLC. Global Credit Research- 24 Sep 2019. Paris, September 24, 2019-- Moody's Investors Service has completed a periodic review of the ratings of AstraZeneca PLC and other ratings that are associated with the same analytical unit.
Moody's changes outlook on AstraZeneca's A3 ratings to stable; affirms...
Rating Action: Moody's changes outlook on AstraZeneca's A3 ratings to stable; affirms ratings. Global Credit Research- 02 Apr 2019. Paris, April 02, 2019-- Moody's Investors Service has today affirmed AstraZeneca PLC's A3 senior unsecured rating, its A3 senior unsecured medium-term note program rating, its A3 senior unsecured shelf rating and the short-term rating commercial paper at P-2.
- Please Change Name Knut Slatten
Moody's changes outlook on AstraZenaca's A3 rating to negative; affirm...
Rating Action: Moody's changes outlook on AstraZenaca's A3 rating to negative; affirms ratings. Global Credit Research- 28 Jul 2017. London, 28 July 2017-- Moody's Investors Service has today changed to negative from stable the outlook on the A3/ A3 long-term ratings of British pharmaceutical company AstraZeneca Plc and A3 long term rating of its guaranteed subsidiary.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.